Kamal Bharucha
About
Kamal Bharucha is a scholar working on Hematology, Speech and Hearing and Molecular Biology.
According to data from OpenAlex, Kamal Bharucha has authored 23 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 7 papers in Speech and Hearing and 6 papers in Molecular Biology. Recurrent topics in Kamal Bharucha's work include Autoimmune and Inflammatory Disorders Research (12 papers), Adolescent and Pediatric Healthcare (7 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). Kamal Bharucha is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (12 papers), Adolescent and Pediatric Healthcare (7 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). Kamal Bharucha collaborates with scholars based in United States, United Kingdom and Italy. Kamal Bharucha's co-authors include Paul T. Tarr, S Lawrence Zipursky, Robert G. Bergman, Robert E. Minto, Jianmei Wang, Erik J. Sorensen, Fabrizio De Benedetti, K. C. Nicolaou, Robert P. Discordia and Hermine I. Brunner and has published in prestigious journals such as Journal of the American Chemical Society, Annals of the Rheumatic Diseases and Journal of Experimental Biology.
In The Last Decade
Kamal Bharucha
22 papers receiving 481 citations
Peers
Kamal Bharucha
Stefan Klauser Switzerland
Mariateresa Allocca Italy
Ronald C. Peterson United States
Åsa Andersson Australia
Wendy L. White United States
Suzanne M. Curtis Australia
Cihan Erkut Germany
Astrid Spannhoff United States
Sandrine Braud France
Citations per year, relative to Kamal Bharucha Kamal Bharucha (= 1×)
peers
Stefan Klauser
Countries citing papers authored by Kamal Bharucha
Since
Specialization
Citations
This map shows the geographic impact of Kamal Bharucha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kamal Bharucha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kamal Bharucha more than expected).
Fields of papers citing papers by Kamal Bharucha
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Kamal Bharucha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kamal Bharucha. The network helps show where Kamal Bharucha may publish in the future.
Co-authorship network of co-authors of Kamal Bharucha
This figure shows the co-authorship network connecting the top 25 collaborators of Kamal Bharucha. A scholar is included among the top collaborators of Kamal Bharucha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kamal Bharucha. Kamal Bharucha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Bharucha, Kamal. (2024). Multisystemic Sarcoidosis Culminating in Asymptomatic Complete Heart Block. A5904–A5904.
2.
Bharucha, Kamal, Debra F. Weinstein, Richard J. Auchus, et al.. (2022). ODP046 Initial Lessons from a Prescreening Protocol to Identify Participants with Classic CAH Potentially Eligible for Gene Therapy Treatment with BBP-631, an Adeno-associated Virus (AAV) Serotype 5-Based Recombinant Vector Encoding the Human CYP21A2 Gene. Journal of the Endocrine Society. 6(Supplement_1). A60–A61.
3.
Merke, Deborah P., Richard J. Auchus, Kyriakie Sarafoglou, et al.. (2021). Design of a Phase 1/2 Open-Label, Dose-Escalation Study of the Safety and Efficacy of Gene Therapy in Adults With Classic Congenital Adrenal Hyperplasia (CAH) Due to 21-hydroxylase Deficiency Through Administration of an Adeno-Associated Virus (AAV) Serotype 5-Based Recombinant Vector Encoding the Human CYP21A2 Gene. Journal of the Endocrine Society. 5(Supplement_1). A82–A82.
4.
Pardeo, Manuela, Jianmei Wang, Nicolino Ruperto, et al.. (2019). Neutropenia During Tocilizumab Treatment Is Not Associated with Infection Risk in Systemic or Polyarticular-course Juvenile Idiopathic Arthritis. The Journal of Rheumatology. 46(9). 1117–1126.
5.
Bharucha, Kamal, Hermine I. Brunner, Inmaculada Calvo Penadés, et al.. (2018). Growth During Tocilizumab Therapy for Polyarticular-course Juvenile Idiopathic Arthritis: 2-year Data from a Phase III Clinical Trial. The Journal of Rheumatology. 45(8). 1173–1179.
6.
Benedetti, Fabrizio De, Nicolino Ruperto, Daniel J. Lovell, et al.. (2017). THU0503 Identification of optimal subcutaneous (SC) doses of tocilizumab in children with polyarticular-course juvenile idiopathic arthritis (PCJIA). Annals of the Rheumatic Diseases. 76. 396–396.
7.
Ramanan, Athimalaipet V, Fabrizio De Benedetti, Nicolino Ruperto, et al.. (2017). 06. Identification of optimal subcutaneous doses of tocilizumab in children with polyarticular-course juvenile idiopathic arthritis. Lara D. Veeken. 56(suppl_6).
8.
Monemi, Sharareh, Erhan Berber, Khaled Sarsour, et al.. (2016). Incidence of Gastrointestinal Perforations in Patients with Rheumatoid Arthritis Treated with Tocilizumab from Clinical Trial, Postmarketing, and Real-World Data Sources. Rheumatology and Therapy. 3(2). 337–352.
9.
Benedetti, Fabrizio De, Hermine I. Brunner, Nicolino Ruperto, et al.. (2014). Catch‐Up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis: Results From a Phase III Trial. Arthritis & Rheumatology. 67(3). 840–848.
10.
Benedetti, Fabrizio De, Nicolino Ruperto, Eileen Baildam, et al.. (2014). A14: Neutropenia With Tocilizumab Treatment Is Not Associated With Increased Infection Risk in Patients With Systemic Juvenile Idiopathic Arthritis. Arthritis & Rheumatology. 66(S3).
11.
Brunner, Hermine I., Nicolino Ruperto, Zbigniew Żuber, et al.. (2014). A4: Efficacy and Safety of Tocilizumab in Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis: 2‐Year Data From CHERISH. Arthritis & Rheumatology. 66(S3).
12.
Benedetti, Fabrizio De, Nicolino Ruperto, Graciela Espada, et al.. (2014). Catch-up growth during tocilizumab therapy for systemic juvenile idiopathic arthritis: 2-year data from a phase 3 clinical trial. Lara D. Veeken. 53(suppl_3). iii1–iii1.
13.
Benedetti, Fabrizio De, Nadina Rubio‐Pérez, Steven I. Goodman, et al.. (2014). A45: Neutropenia With Tocilizumab Treatment Is Not Associated With Increased Infection Risk in Patients With Polyarticular‐Course Juvenile Idiopathic Arthritis. Arthritis & Rheumatology. 66(S3).
14.
Benedetti, Fabrizio De, Nicolino Ruperto, Zbigniew Żuber, et al.. (2013). PReS-FINAL-2180: Efficacy and safety of tocilizumab (TCZ) in patients with polyarticular-course juvenile idiopathic arthritis (pcJIA): 2-year data from CHERISH. Pediatric Rheumatology. 11(S2).
15.
Benedetti, Fabrizio De, Nicolino Ruperto, Graciela Espada, et al.. (2013). SAT0438 Catch-Up Growth During Tocilizumab Therapy for Systemic Juvenile Idiopathic Arthritis: 2-Year Data from a Phase 3 Clinical Trial. Annals of the Rheumatic Diseases. 72. A729–A730.
16.
Benedetti, Fabrizio De, Eileen Baildam, Rubén Burgos‐Vargas, et al.. (2013). PReS-FINAL-2140: Neutropenia with Tocilizumab (TCZ) treatment is not associated with increased infection risk in patients with systemic juvenile idiopathic arthritis (SJIA). Pediatric Rheumatology. 11(S2).
17.
Bharucha, Kamal. (2009). The Epicurean Fly: Using Drosophila Melanogaster to Study Metabolism. Pediatric Research. 65(2). 132–137.
18.
Nicolaou, K. C., Erik J. Sorensen, Robert P. Discordia, et al.. (1992). Zehngliedrige cyclische Endiine mit bemerkenswerten chemischen und biologischen Eigenschaften. Angewandte Chemie. 104(8). 1094–1096.
19.
Bharucha, Kamal, et al.. (1992). Double cycloaromatization of (Z,Z)-deca-3,7-diene-1,5,9-triyne: evidence for the intermediacy and diradical character of 2,6-didehydronaphthalene. Journal of the American Chemical Society. 114(8). 3120–3121.
20.
Zieger, Herman E., et al.. (1987). The synthesis of neophyllithium and its reaction with anthracene. Tetrahedron Letters. 28(48). 5989–5992.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Stefan Klauser Breakdown of academic impact, for papers by Mariateresa Allocca Breakdown of academic impact, for papers by Ronald C. Peterson Breakdown of academic impact, for papers by Åsa Andersson Breakdown of academic impact, for papers by Wendy L. White Breakdown of academic impact, for papers by Suzanne M. Curtis Breakdown of academic impact, for papers by Cihan Erkut Breakdown of academic impact, for papers by Astrid Spannhoff Breakdown of academic impact, for papers by Sandrine Braud Breakdown of academic impact, for papers by Kumiko Yoshizawa‐Kumagaye